ASX-Dividend-Report-Banner

Wingderm® Has Unveiled the Latest Research of Mesoskin for Mesotherapy Treatment at AMWC

October 24, 2023 12:23 PM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Wingderm® Has Unveiled the Latest Research of Mesoskin for Mesotherapy Treatment at AMWC
Image source: Kalkine Media

BEIJING, Oct. 24, 2023 /PRNewswire/ -- On October 20-22, 2023, the Aesthetic & Anti-Aging Medicine World Congress (AMWC) was held in Chengdu, China. A wide range of aesthetic plastic surgery products and technologies made their appearance at this event, Wingderm®'s Latest Research of Mesoskin for Mesotherapy Treatment have captured the attention of experts, practitioners, and beauty seekers.

Research of Mesoskin for Mesotherapy Treatment
Professor Wang Hang, the Executive Director of AMWC and Chief of The Department of Plastic Surgery and Cosmetic Dematology, West China stomatological Hospital, Sichuan university, delivered a speech as a guest speaker at the Facial Rejuvenation Forum, with the topic of "Research of Mesoskin for Mesotherapy Treatment". The EPM technology utilized in Mesoskin from Wingderm® served as the research subject in this clinical trial.

Multiple clinical trial results show that compared to transdermal introduction methods such as nanocrystals, derma rollers, and water injections, EPM technology results in less skin damage, higher permeability and more even subcutaneous hyaluronic acid distribution in the delivery of 150KDa hyaluronic acid, it performs well in both skin experience and treatment efficacy. This research achievement once again reaffirmed the comprehensive advantages of Mesoskin for Mesotherapy Treatment in transdermal delivery.

After the speech, Wingderm® Vice President Ms. Xu Ren presented a certificate to Professor Wang Hang to express gratitude for her significant contributions to Research of Mesoskin. Ms. Xu Ren said, Wingderm® will engage in more research and verification of innovative technologies and products that cater to market demands.

Ms. Xu Ren & Professor Hang Wang
Ms. Xu Ren & Professor Hang Wang

About EPM Technology
EPM, first introduced by Wingderm® in 2018, creatively combines electroporation and hollow microchip. It aims to improve the absorption rate of nutrients, reduce pain sensation, and enhance the treatment experience. The commercialization of EPM technology resulted in the groundbreaking product Mesoskin, which caused a sensation in the industry shortly after it was launched. This almost painless, non-invasive, and effective treatment method has been recognized and recommended by experts and scholars worldwide and has been widely used global beauty salons and clinics. EPM transdermal introduction represents a breakthrough advancement in the industry and possesses significant market potential.

About Wingderm®
Wingderm® since its establishment in 2016, with the aim of "Aesthetics & Technology, Easy to Achieve", provide leading and reliable intelligent optoelectronic medical equipments, which are exported to 80+ countries including Europe, America, and the Middle East. 10,000+ devices have been deployed and treated 100,000+ beauty seekers worldwide. For further information:https://www.wingderm.com/


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.